Evidence assembled here indicates that when olive oil forms a major part of dietary fat in controlled human experiments, total and LDL-cholesterols are somewhat higher than when the same amount of fat is one of the modern predominantly monounsaturated oils: low erucic rapeseed or high oleic sun¯ower oil. Oils rich in monounsaturated fatty acids thus do not all have the same effect on plasma cholesterol. This phenomenon is explicable by consideration of the content of other fatty acids and the non-saponi®able fractions of the different monounsaturated oils. It helps to explain the discrepancy that has existed between the classic experiments (using olive oil), which found monounsaturated oils`neutral', and some of the more recent experiments which found them more cholesterol-lowering than carbohydrates. Four published meta-analyses are reviewed. The three which included most of the published experiments show that monounsaturated fatty acids (MUFA) have less plasma cholesterol-lowering effect than polyunsaturated fatty acids.
In the original human experiments on the effect of different fats and oils on plasma cholesterol (Ahrens et al, 1957; Malmros & Wigand, 1957; Keys et al, 1957; Hegsted et al, 1965; Vergroesen & De Boer, 1971 ) and others all found that oleic acid (18:1, o-9), the major monounsaturated fatty acid, had little or no plasma cholesterol-lowering effect compared with linoleic acid (18:2, o-6), the predominant dietary polyunsaturated fatty acid, which gave consistently lower plasma cholesterols. Keys et al (1958) expressed the effect of oleic acid as neutral, not different in its effect on plasma cholesterol from an equivalent amount of carbohydrate. They calculated that the coef®cient for monounsaturated fatty acids (MUFA) in the regression equation:
was so small (and not statistically signi®cantly different from zero), that it is ignored in the usual form of Keys' predictive equation Anderson et al, 1957) :
In equations (1) and (2) D fat class is the change of fat class expressed as percent of total calorie intake. All these researchers measured only total plasma cholesterol and they used olive oil to represent predominantly MUFA oils, namely oils rich in 18:1 cis (Ahrens et al, 1957; Malmros & Wigand, 1957; Hegsted et al, 1965; Vergroesen & De Boer, 1971; Keys et al, 1958) . Olive oil was the obvious oil to choose. Low erucic rapeseed oil (canola) and high-oleic sun¯ower and saf¯ower oils were not then generally available. The rule that MUFAs have a neutral effect prevailed for 30 y and was re¯ected in authoritative dietary recommendations (for example, American Heart Association, 1973; Joint Working Party, 1976) .
But Mattson & Grundy (1985) reported that MUFA gave the same lowering of plasma LDL cholesterol as polyunsaturated oil in metabolic ward experiments. Plasma total cholesterol was slightly lower on the polyunsaturated diet but this was because HDL cholesterol was a little lower. The next year Grundy (1986) reported that MUFA oil was not neutral compared to carbohydrate Ð plasma LDL and total cholesterols were lower with MUFA oil compared to low-fat, high carbohydrate, and HDL cholesterol was higher. Grundy's MUFA rich oils were high-oleic saf¯ower oil.
This appeared to be another example of nutritionists changing their minds and advice. It was hard to understand how Keys and the other earlier investigators had all got it wrong. One possible explanation is that Grundy et al (1986) used liquid formula diets (Hegsted & Nicolosi, 1990) ; another is that their mono and poly diets both had very high P/S ratios (3.0 and 7.5 respectively). They had however differentiated LDL, HDL and VLDL cholesterol. While their reports were being considered the oxidised LDL hypothesis for atherogenesis was proposed (Steinberg et al, 1989) and the fact that in vitro MUFA are not liable to autoxidation, but polyunsaturated fatty acids are (Pryor, 1994) , added another reason for re-evaluation of the role of MUFAs (Mattson, 1989) .
In subsequent research some papers have supported Grundy's ®ndings (Wardlaw et al, 1991), others have not (Carmena et al, 1996; Dreon et al, 1990) . Some experts expressed opinions such as`we now know that diets high in MUFA are as effective as those rich in polyunsaturated fatty acids (PUFA) in lowering serum cholesterol but, in contrast to the effect of n-6 PUFA, MUFA do not lower HDL' (Ulbricht & Southgate, 1991) . Of®cial recommendations are more cautious. For COMA in the UK`Substitution of saturates by monounsaturates reduces plasma levels of total and LDL cholesterol to about the same extent as substitution by carbohydrates F F F . There is only inconsistent evidence that monounsaturates per se actively reduce LDL cholesterol' (Department of Health, 1994) .
In a situation like this meta-analysis might be helpful. Four have now been published. They differ considerably in design and selection of studies. Mensink & Katan (1992) selected 27 trials published between 1972 and 1992 involving 682 subjects. Their selection criteria looked for good dietary control, descriptions that allowed calculation of intake of fatty acid classes and good design. They concluded that all fatty acids increase HDL cholesterol but the effect diminishes with increasing degree of unsaturation. The regression equation for LDL cholesterol showed a signi®cant negative (namely, lowering) coef®cient for polyunsaturates, not for MUFA (Table 1) . Hegsted et al (1993) included the whole literature, including early papers that only reported total cholesterol, with a few exceptions: formula diets or very short experimental periods. They separately analysed 50 papers reporting metabolic ward experiments and 37 ®eld study experiments, and focused on serum total cholesterol. In regression equations for both sets of data, saturates had positive and polyunsaturates negative coef®cients but again the coef®cient for MUFA was not statistically signi®cantly different from zero (Table 1) . Clarke et al (1997) include 71 papers (5076 subjects) in their meta-analysis but analyse separately the eight papers that used formula diets (overall effect of saturated fatty acids were less in these). In the 63 papers reporting`solid food diets' blood total and LDL cholesterols were signi®-cantly increased by saturated and decreased by polyunsaturated fatty acids; MUFA produced no signi®cant effect (Table 1) . There was no signi®cant difference in the small positive effects of MUFA and polyunsaturates on HDL cholesterol.
These three meta-analyses all reach substantial agreement (Table 1 ). The fourth meta-analysis (Gardner & Kraemer, 1995) comes to different conclusions but it only included 14 papers, a minority sample of all the published human experiments. Gardner & Kraemer's (1995) results indicated no signi®cant differences in total LDL or HDL cholesterol when oils high in MUFA or polyunsaturated fatty acids were compared. They did not publish a regression equation. Surprisingly they do not appear to have been aware of the meta-analysis by Mensink & Katan (1987) three years earlier in the same journal.
A possibility mentioned in discussion by a few authors (Hegsted et al, 1993; Gardner & Kraemer, 1995) is that average samples of speci®c plant oils rich in MUFA might differ somewhat in their effect on plasma cholesterol. While investigating the possibility that palmitic acid (16:0), and hence palmolein, may be less cholesterolraising than myristic and lauric acids and oils rich in these (Hayes et al, 1991) we happened to compare in turn, in three separate sets of human experiments (21± 42 subjects per experiment) plasma total, LDL and HDL cholesterol on palmolein against three MUFA rich oils: canola, olive and high-oleic sun¯ower oils. Palmolein contains more saturated and less MUFA (Table 3) . We found that total and LDL cholesterols were lower on canola oil than on palmolein (Truswell et al, 1992) and on higholeic sun¯ower oil than on palmolein (Choudhury et al, 1997) as predicted by the Keys et al (1957) equation, but they were not lower on olive oil than on palmolein (Choudhury et al, 1995) . HDL cholesterols averaged 0.10 mmol/l higher on palmolein than on each of the three MUFA oils. The same results of these three comparisons have been reported by others (Table 2) : lower cholesterols on canola cf. palmolein (Sundram et al, 1995) and on high oleic sun¯ower oil cf. palmolein (Denke & Grundy, 1992; Noakes et al, 1996; Cater et al, 1997) likewise the same plasma cholesterols on olive oil as on palmolein (Ng et al, 1992) . By deduction plasma cholesterol should therefore be higher on olive oil than on canola oil or on high-oleic sun¯ower oilÐand these results have recently been reported in direct comparisons (Lichtenstein et al, 1993; Perez-Jimenez et al, 1995) (Table   Table 2 Mean plasma cholesterols & LDL-cholesterols, mmol/l, in crossover paired comparisons of predominantly monounsaturated oils against another monounsaturated oil or against the more saturated palmolein a Plasma cholesterol signi®cantly lower than on the oil being compared. Monounsaturated oils do not all have the same effect on plasma cholesterol AS Truswell and N Choudhury 2). In animals too plasma LDLs were higher on olive oil or olive/saf¯ower (2:1) than on canola/palm oil (9:1) in guinea pigs; hepatic LDL receptors were more abundant on the canola/palm oil diet (Fernandez et al, 1996) . In rats olive oil leads to higher concentrations of cholesterol in the liver than diets with saturated or polyunsaturated fatty acids (Beynen, 1989) . In cynomolgus monkeys a polyunsaturated fat diet increased the fractional catabolic rate of apo B lipoprotein; this was not seen on a monounsaturated fat diet (Brousseau et al, 1993) . The relatively high plasma cholesterol with olive oil compared to other MUFA oils is consistent with the unexpected ®nding that Cretan boys had similar plasma cholesterols to boys in the USA and Holland, though their dietary fat was mainly olive oil (Aravanis et al, 1988a; . Middle-aged men in Crete do not show low plasma cholesterol either nowadays; they averaged 5.5 mmol/l in 1988 (Aravanis et al, 1988b) .
If olive oil usually gives higher plasma cholesterols than other MUFA oils this could explain the discrepancy between the results of Grundy's group and those of the earlier human experiments.
The shorthand description that an oil is (predominantly) monounsaturated omits details of the fatty acid pattern that can in¯uence plasma cholesterol levels (Table 3) . Canola oil contains more polyunsaturated fatty acids than olive oil. High-oleic sun¯ower oil contains only 4% saturates against 14% in olive oil while both contain about the same 10% of polyunsaturated fatty acids. High-oleic saf¯ower contains 8% saturates (less than olive oil) and 18% polyunsaturates (more than olive oil). Hence olive oil should tend, on Keys' formula, to give higher plasma cholesterols than the other three MUFA oils. Differences in the non-saponi®able lipids (Table 3 ) between these oils probably work in the same direction. Olive oil contains much more squalene than other vegetable oils, about 500 mg per 100 g (Perez-Jiminez et al, 1995; Miettinen & Vanhanen, 1994) . Indeed squalene is used by food technologists to identify the presence of olive oil (Belitz & Grosch, 1987) . Squalene is on the pathway of cholesterol biosynthesis; at 1 g per day intake it has been shown to raise plasma total and LDL cholesterol by 12% (Miettinen & Vanhanen, 1994) . Thirdly the other MUFA oils contain three times as much phytosterols, 250 ± 440 mg/100 g, as against 110 mg/100 ml in olive oil (Perez-Jimenez et al, 1995; Scherz & Senser, 1994; Lichtenstein et al, 1994) . These plant sterols interfere with cholesterol (animal sterol) absorption; b-sitosterol was an early drug treatment for hypercholesterolaemia. The usual dose was 3 g with meals thrice daily but in one experiment 600 mg per day appeared to lower plasma cholesterol (Beveridge et al, 1964) .
As to comparison of the effect of oils vs carbohydrates, this looks different when LDL and HDL cholesterols are measured instead of only plasma total cholesterol. In modern experiments Mensink & Katan (1987) con®rmed Keys' classic result. When 20% of energy as carbohydrates was replaced by olive oil there was no difference in plasma total cholesterol. But HDL cholesterol was signi®cantly higher on olive oil and triglycerides lower than on carbohydrate. This is because in short term experiments HDL cholesterol tends to be lower when carbohydrate is substituted for any fat or oil (changing at more than 10% of dietary energy) (Truswell, 1994) . In another experiment found that LDL-cholesterols, like total cholesterols did not differ when olive oil was exchanged for carbohydrate.
Does the realisation that olive oil gives somewhat higher plasma cholesterols than other MUFA oils affect the standing of the Mediterranean diet as a nutritional ideal? Not fundamentally. There are 17 Mediterranean countries and many Mediterranean diets; olive oil is only one component of the traditional concept, along with plentiful vegetables, fruit, high glycaemic index cereals, pulses and wine, more ®sh than red meat (Ferro-Luzzi & Sette, 1989) . Olive oil cannot explain the French paradox; the French nation only obtains 2% of dietary energy from this food (Ferro-Luzzi & Leclerq, 1997) . Olive oil certainly gives lower plasma cholesterol than butter (Ahrens et al, 1957) , even if newer MUFA oils and polyunsaturated oils can produce still lower cholesterols, and it is hypothesised that the polyphenols in virgin olive oil may act in vivo as protective antioxidants (Wiseman et al, 1996) . Other MUFA oils have negligible amounts of these polyphenols (Colquhoun et al, 1996) , although they usually contain more vitamin E than olive oil (Bauernfeind, 1980) . Note: Fatty acids percentages based on analyses for experiments in Table 2 . Most range AE 5% total FAs.
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